Publicacións en colaboración con investigadores/as de Universidad de Cantabria (22)

2024

  1. An account on the history of pharmacology in Spain

    Pharmacological Research

  2. Corrigendum to: An account on the history of pharmacology in Spain [Pharmacol. Res. 202 (2024) 107104 Pages 1–11 https://doi.org/10.1016/j.phrs.2024.107104] (Pharmacological Research (2024) 202, (S1043661824000483), (10.1016/j.phrs.2024.107104))

    Pharmacological Research

2023

  1. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  2. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies

    Neurology: Genetics, Vol. 9, Núm. 4

2020

  1. Strength plus endurance training and individualized diet reduce fat mass in overweight subjects: A randomized clinical trial

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 7

2017

  1. MIC of amoxicillin/clavulanate according to CLSI and EUCAST: Discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1478-1487

2016

  1. Autophagy resolves early retinal inflammation in Igf1-deficient mice

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 9, pp. 965-974

  2. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2125-2130

  3. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

  4. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530

2015

  1. Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 8, pp. 2306-2310

2014

  1. Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: A multicenter external proficiency study using a well-defined collection of escherichia coli strains

    Journal of Clinical Microbiology, Vol. 52, Núm. 1, pp. 122-129

2013

  1. The Spanish Antibiogram Committee (COESANT), in step with EUCAST

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 10, pp. 639-640

2012

  1. Nutrition and physical activity programs for obesity treatment (PRONAF study): Methodological approach of the project

    BMC Public Health, Vol. 12, Núm. 1

2011

  1. Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-β-lactamase-producing Escherichia coli clones from humans

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2451-2457

2008

  1. Birth weight and blood lipid levels in Spanish adolescents: Influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study

    BMC Medical Genetics, Vol. 9

2007

  1. Body fat distribution reference standards in Spanish adolescents: The AVENA Study

    International Journal of Obesity, Vol. 31, Núm. 12, pp. 1798-1805

  2. Effect of the Ala12 allele in the PPARγ-2 gene on the relationship between birth weight and body composition in adolescents: The AVENA study

    Pediatric Research, Vol. 62, Núm. 5, pp. 615-619

2006

  1. Anthropometric body fat composition reference values in Spanish adolescents. The AVENA Study

    European Journal of Clinical Nutrition, Vol. 60, Núm. 2, pp. 191-196

  2. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: The AVENA Study

    American Journal of Clinical Nutrition, Vol. 84, Núm. 3, pp. 505-512